GXP PHARMAID ApS: Financial statements 2020
CVR: 29615861
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,798,982 and a net result of DKK 960,283 compared with DKK -168,984 the year before. That is an increase of 267.1% compared with the year before. Equity in the 2020 report amounted to DKK 1,695,248. The solvency ratio was 56.8%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,798,982
- Profit/Loss
- DKK 960,283
- Equity
- DKK 1,695,248
- Total Assets
- DKK 2,983,924
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
Official annual report
How creditworthy is GXP PHARMAID ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
GXP PHARMAID ApS has published its annual report for 2019. Gross profit came to DKK 762,547, and the net result was DKK -168,984.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.